COMBINATION THERAPY FOR SMALL CELL LUNG CANCER

摘要

A method for treatment of small cell lung cancer that does not respond to first-line treatment or that progresses following cessation of first-line organoplatinum chemotherapy is provided that includes the administration of picoplatin and paclitaxel, optionally in conjunction with a regimen of best supportive care. Multiple doses of picoplatin and paclitaxel can be co-administered.